Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604] (EBioMedicine (2020) 51, (S2352396419308199), (10.1016/j.ebiom.2019.102604))

Zhaolai Qi, Ting Zhang, Lei Song, Hongyong Fu, Haifeng Luo, Jie Wu, Shuyun Zhao, Tianhua Zhang, Lianying Guo, Lingling Jin, He Zhang, Gena Huang, Tonghui Ma, Yingjie Wu, Lin Huang

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604] (EBioMedicine (2020) 51, (S2352396419308199), (10.1016/j.ebiom.2019.102604))'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds